Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 8/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7910413 | 0.97 | ACACB (0.40) | ACACBFFAR1 | |
| SCHEMBL9512427 | 0.92 | TSHR (0.43) | ACACBTSHRHSD17B10FFAR1 | |
| SCHEMBL9508712 | 0.92 | ACACB (0.41) | ACACBTSHRHSD17B10FFAR1 | |
| SCHEMBL9509982 | 0.91 | TSHR (0.39) | ACACBTSHRHSD17B10 | |
| SCHEMBL9509905 | 0.91 | HSD17B10 (0.48) | ACACBTSHRHSD17B10 | |
| SCHEMBL9510052 | 0.90 | TSHR (0.41) | ACACBTSHRHSD17B10FFAR1FFAR4 | |
| SCHEMBL9509273 | 0.90 | HSD17B10 (0.50) | TSHRHSD17B10 | |
| SCHEMBL9509231 | 0.90 | HSD17B10 (0.50) | TSHRHSD17B10 | |
| SCHEMBL9511465 | 0.89 | ACACB (0.39) | ACACBTSHRHSD17B10FFAR1FFAR4 | |
| SCHEMBL9512494 | 0.89 | ACACB (0.42) | ACACBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308438-B1 | LIQUID CRYSTAL PHASE CONTAINING TOLANES | MERCK PATENT GmbH (DE) | 1993-09-29 | — | — | EP | disclosed |